CH588491A5 - Prep. of oxoalkylxanthine - this has e.g. broncholytic and fibrinolytic activity - Google Patents
Prep. of oxoalkylxanthine - this has e.g. broncholytic and fibrinolytic activityInfo
- Publication number
- CH588491A5 CH588491A5 CH1019873A CH1019873A CH588491A5 CH 588491 A5 CH588491 A5 CH 588491A5 CH 1019873 A CH1019873 A CH 1019873A CH 1019873 A CH1019873 A CH 1019873A CH 588491 A5 CH588491 A5 CH 588491A5
- Authority
- CH
- Switzerland
- Prior art keywords
- dimethylxanthine
- hours
- hydroxy
- dependent
- dehydrogenation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/10—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/145—Fungal isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/07—Bacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/20—Flavobacterium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/38—Pseudomonas
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/66—Aspergillus
- C12R2001/69—Aspergillus oryzae
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19722234202 DE2234202A1 (de) | 1972-07-12 | 1972-07-12 | Verfahren zur herstellung von oxoalkylxanthinen |
DE19732302772 DE2302772C2 (de) | 1973-01-20 | 1973-01-20 | Mikrobiologisches Verfahren zur Herstellung von Oxoalkylxanthinen |
DE19732330741 DE2330741A1 (de) | 1973-06-16 | 1973-06-16 | Verfahren zur herstellung von oxoalkylxanthinen |
Publications (1)
Publication Number | Publication Date |
---|---|
CH588491A5 true CH588491A5 (en) | 1977-06-15 |
Family
ID=27184566
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH1019873A CH588491A5 (en) | 1972-07-12 | 1973-07-12 | Prep. of oxoalkylxanthine - this has e.g. broncholytic and fibrinolytic activity |
Country Status (5)
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0157098A1 (en) * | 1980-06-21 | 1985-10-09 | Beecham Wuelfing GmbH & Co KG | Xanthine derivatives, pharmaceuticals compositions containing them and a process for their preparation |
AU1868195A (en) * | 1994-01-28 | 1995-08-15 | Cell Therapeutics, Inc. | Cell signaling inhibitors |
-
1973
- 1973-07-07 ES ES416696A patent/ES416696A1/es not_active Expired
- 1973-07-11 JP JP7756073A patent/JPS5422517B2/ja not_active Expired
- 1973-07-12 NL NL7309709A patent/NL7309709A/xx unknown
- 1973-07-12 CH CH1019873A patent/CH588491A5/de not_active IP Right Cessation
- 1973-07-12 SE SE7309835A patent/SE400289B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ES416696A1 (es) | 1976-02-16 |
NL7309709A (US20110009641A1-20110113-C00116.png) | 1974-01-15 |
JPS4951298A (US20110009641A1-20110113-C00116.png) | 1974-05-18 |
JPS5422517B2 (US20110009641A1-20110113-C00116.png) | 1979-08-07 |
SE400289B (sv) | 1978-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2021465C3 (de) | Verfahren zur Herstellung eines Enzympräparates, welches die OH-Gruppe in der ibeta-Stellung des Cholesterin« dehydriert | |
DE2849696A1 (de) | Verfahren zur herstellung des antibiotikums c-15003 p-3 | |
CH588491A5 (en) | Prep. of oxoalkylxanthine - this has e.g. broncholytic and fibrinolytic activity | |
DE2302772C2 (de) | Mikrobiologisches Verfahren zur Herstellung von Oxoalkylxanthinen | |
DE1299797B (de) | Verfahren zur Herstellung des Antibioticums Rhi-12-648 | |
DE1155413B (de) | Verfahren zur biotechnischen Herstellung von Gibberellinsaeure | |
DE1958587B2 (de) | Verfahren zur biochemischen abtrennung von l-menthol | |
DE1643149A1 (de) | Verfahren zur Oxydation von Adamantanverbindungen | |
DE1793697B2 (de) | Optisch aktive 1-hydroxy-3-oxo-2- methyl-2-(3'-oxo-6'-carbo-niedrig-alkoxy) -hexyl-cyclopentane | |
DE2849393C2 (de) | Verfahren zur biotechnischen Herstellung von 2,5-Diketogluconsäure | |
DE1929114C3 (de) | Verfahren zur Herstellung von Rifamycin-L | |
DE1229522B (de) | Verfahren zur Herstellung von Cycloalkanolen und/oder Cycloalkanonen sowie von Estern der Cycloalkanole | |
EP0014991A1 (de) | Mikrobiologisches Verfahren zur Herstellung 7-alpha-hydroxylierter Steroide | |
DE960816C (de) | Verfahren zur Herstellung oxydierter Steroide | |
DE1171413B (de) | Verfahren zur Herstellung von 5-Keto-fruktose durch Gaerung | |
DE1695364C (de) | Verfahren zur Herstellung von 2 Nitroimidazolen | |
EP0496854B1 (de) | Verfahren zur Herstellung von 20-METHYL-5,7-PREGNADIEN-3$g(b),21-DIOL-DERIVATIVEN | |
DE2129650C2 (de) | Verfahren zur Herstellung von (-)-5(S)-Hydroxy-9-oxodecansäurelacton | |
DE1107225B (de) | Verfahren zur Herstellung von 1, 4, 17(20)-Pregnatrienen | |
DE3051206C2 (de) | Verfahren zur fermentativen Herstellung von Monacolin K | |
DE3248420C2 (US20110009641A1-20110113-C00116.png) | ||
AT265531B (de) | Verfahren zur Herstellung neuer heterocyclischer Verbindungen | |
DE2425582B2 (de) | Verfahren zur herstellung von hydroxycyclopentenonderivaten | |
DE2801399A1 (de) | Fermentationsverfahren | |
DE1120072B (de) | Verfahren zur Herstellung von gegebenenfalls N-substituierten 6-[Ureido-N']-penicillansaeuren in Submerskultur |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |